Aristotle University Of Thessaloniki (AUTH)
Η επίδραση της απροτινίνης στη σπλαχνική ισχαιμία – επαναιμάτωση από πνευμοπεριτόναιο: πειραματική μελέτη σε επίμυες
Abstract
dc:descriptionThe study of the pathophysiological effects of pneumoperitoneum in the circulatory system, respiratory system and especially splanchnic circulation resulted in numerous publications mainly in the 90s. Μeasurements of blood flow in the branches of the abdominal aorta showed a decrease, which was proportional to intraabdominal pressure. Either high intraabdominal pressure or atherosclerosis and stenoses of blood vessels may lead to more severe splanchnic ischemia, followed by the phase of reperfusion after pneumoperitoneum discontinuation. Therefore, it is argued that elevated intra-abdominal pressure during insufflation activates the mechanisms of ischemia - reperfusion syndrome.Ischemia - reperfusion syndrome includes pathophysiological changes induced by reperfusion of tissues being previously under ischemia. The primary step in the sequence of these processes is the production of free radicals, which have a direct toxic effect on the cells and trigger the inflammatory response. Ischemia – reperfusion syndrome in liver occurs frequently in clinical practice either due to vascular occlusion during hepatectomy or within hepatic transplantation. The reperfusion injury in the small intestine causes intestinal barrier disruption and migration of bacteria and endotoxins from the intestinal lumen into the portal and then the systemic circulation. The final induction of systemic inflammatory response (SIRS) involves the damage of distant organs (remote injury) and progression to multiple organ dysfunction syndrome (MODS).Aprotinin, a protease inhibitor, has been used in experimental protocols of ischemia - reperfusion with beneficial effects. The anti-inflammatory and antioxidant effects of aprotinin mainly lies on the reduction of the expression of adhesion molecules in the endothelium, the degradation of elastase and cathepsin, the reduced production of myeloperoxidase and phospholipase D by neutrophils and finally the decreased production of proinflammatory cytokines.We used 60 male Albino Wistar rats, which were randomly divided into three groups of 20 animals each. Τhe first was the Sham group. In the second group (Control group, C) pneumoperitoneum with constant pressure of 12mm Hg was maintained for 4 hours. In the third group (Aprotinin group, AP), 4 hour pneumoperitoneum was produced and also aprotinin was administered intraperitoneally in a similar dosage to that used in cardiac surgery. Control and aprotinin groups were randomly divided into two subgroups of 10 animals each with different duration of reperfusion (60 or 180 minutes). Hence subgroups were named as C60, C180, AP60 and AP180. Sacrifice of the rats followed. After middle abdominal and thoracic incision, blood was taken from the heart. Liver, small intestine and lung specimens were collected. Biochemical markers measured were: TNF- a, IL-6, ET-1, CRP, prooxidant – antioxidant balance (PAB) and carbonylated proteins. Hematoxylin - eosin staining was performed for the histological examination and various characteristics of inflammation were evaluated by two pathologists using a five-point scale. The values of most biomarkers in liver were significantly lower in aprotinin subgroups (at least in one or both of them). This result was confirmed by histological examination of liver specimens, since the lesions in animals given the drug were milder, particularly in AP180 subgroup. In the small intestine there was no clear biochemical result in favor of aprotinin. However, in the intestinal specimens inflammation of the small intestine was significantly lower in aprotinin groups. In the lung, both AP60 and AP180 subgroups exhibited milder inflammatory reaction. Finally, plasma measurements showed no difference between groups.In conclusion, aprotinin seems to reduce tissue damage caused by splachnic ischemia - reperfusion induced by pneumoperitoneum. This result, combined with the results of other similar experimental protocols, could be a forerunner for the design of clinical studies in order to investigate the anti-inflammatory effect of the compound in humans.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Baltatzis, Minas
- Μπαλτατζής;, Μηνάς
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40181